Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Immunotherapy|February 24, 2018
Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccineMark O Hardin, Timothy J Vreeland, Guy T Clifton, et al.Oncotargets and Therapy|June 9, 2021
Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal AdenocarcinomaPatrick M McCarthy, Matthew J Rendo, Matthew D Uy, et al.Vaccine|May 5, 2018
Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumorsGarth S Herbert, Timothy J Vreeland, Guy T Clifton, et al.Annals of Surgical Oncology|May 18, 2022
Downstaging of Pancreatic Adenocarcinoma With Either Neoadjuvant Chemotherapy or Chemoradiotherapy Improves SurvivalAnne E O'Shea, Phillip M Kemp Bohan, Elizabeth L Carpenter, et al.Clinical Immunology (Orlando, Fla.)|March 26, 2018
Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune responseTimothy J Vreeland, Jennifer K Litton, Na Qiao, et al.Journal of Cancer|September 14, 2017
Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and OutcomesTimothy J Vreeland, John S Berry Iv, Erika Schneble, et al.Cancer Immunology, Immunotherapy : CII|November 12, 2020
Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreementPhillip M Kemp Bohan, Robert C Chick, Annelies T Hickerson, et al.Journal of Surgical Oncology|May 27, 2024
The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapyElizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy, et al.Vaccine|September 23, 2010
Circulating regulatory T cells (CD4+CD25+FOXP3+) decrease in breast cancer patients after vaccination with a modified MHC class II HER2/neu (AE37) peptideJeremy D Gates, Guy T Clifton, Linda C Benavides, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 30, 2021
Phase I Trial of Encapsulated Rapamycin in Patients with Prostate Cancer Under Active Surveillance to Prevent ProgressionPhillip M Kemp Bohan, Robert C Chick, Anne E O'Shea, et al.Pageof 5